Keyphrases
Nitric Oxide Synthase Inhibitors
100%
Aminoguanidine
100%
Experimental Autoimmune Encephalomyelitis
100%
Inducible Nitric Oxide Synthase
75%
Endothelial Nitric Oxide Synthase (eNOS)
62%
Nitric Oxide Production
25%
Autoimmune Disease
12%
Therapeutic Potential
12%
Selective Inhibitor
12%
Inflammatory Cells
12%
Central Nervous System
12%
Blood Vessels
12%
Clinical Signs
12%
Blood Vessel Wall
12%
Clinical Severity
12%
Nicotinamide Adenine Dinucleotide Phosphate (NADPH)
12%
Enzymatic Activity
12%
Endotoxin
12%
Neuronal Nitric Oxide Synthase (nNOS)
12%
Subcutaneous Injection
12%
Twice Daily
12%
Duration of Illness
12%
Histochemical Staining
12%
Staining Pattern
12%
NADPH-diaphorase
12%
Immunohistochemical Findings
12%
Anterior Horn Cell
12%
Positive Reactivity
12%
Pharmacology, Toxicology and Pharmaceutical Science
Nitric Oxide Synthase
100%
Aminoguanidine
100%
Experimental Autoimmune Encephalomyelitis
100%
Nitric Oxide
25%
Endothelial Nitric Oxide Synthase
25%
Disease
12%
Autoimmune Disease
12%
Cytokine
12%
Reduced Nicotinamide Adenine Dinucleotide Phosphate
12%
Endotoxin
12%
Inducible Nitric Oxide Synthase
12%
Subcutaneous Injection
12%
Neuronal Nitric Oxide Synthase
12%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Dehydrogenase
12%
Neuroscience
Nitric Oxide Synthase
100%
Experimental Autoimmune Encephalomyelitis
100%
Nitric Oxide
25%
Staining Technique
25%
Endothelial Nitric Oxide Synthase
25%
Central Nervous System
12%
Enzyme Activity
12%
Neuronal Nitric Oxide Synthase
12%
Inducible Nitric Oxide Synthase
12%
Reduced Nicotinamide Adenine Dinucleotide Phosphate
12%
Autoimmune Disease
12%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Dehydrogenase
12%
Immunology and Microbiology
Experimental Autoimmune Encephalomyelitis
100%
Cytokine
12%
Inflammatory Cell
12%
Autoimmune Disease
12%
Enzyme Activity
12%
Central Nervous System
12%
Blood Vessels
12%
Body Weight
12%
Staining
12%
Blood Vessel Wall
12%
Anterior Horn Cell
12%